lobbying_activities: 2069128

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2069128	d7edd87d-42bf-4e35-9714-3143347d5fba	Q4	KOUNTOUPES DENHAM CARR & REID, LLC	320918	TEVA PHARMACEUTICALS USA, INC.	2017	fourth_quarter	PHA	Proposals related to affordability and pricing of pharmaceuticals including H. R. 2212 and S.974 Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; H. R. 2051 - FAST Generics Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2018-01-18T17:19:39.547000-05:00